Literature DB >> 15168354

Phosphatidylinositide 3-kinase/AKT in radiation responses.

M Zhan1, Z C Han.   

Abstract

Ionizing or ultraviolet radiation-induced cellular survival signaling pathways induce development of cancer and insensitivity of tumor cells to radiation therapy. Accumulating evidence suggests that the phosphatidylinositide 3-kinase (PI3K)/AKT signal pathway is a major contributor to radioresistance. In many cell types PI3K/AKT signaling is a key cytoprotective response downstream of the EGFR family receptors and mediated carcinogenesis. Cytokines, such as HGF, IGF-I, and IL-6 also protects cells against apoptosis induced by radiation through PI3K/AKT pathway. The mechanics by which PI3K/AKT signaling functions in radiation responses may include its regulation of mitochondrial proteins, transcription factors, translation machinery, and cell-cycle progression. In addition, cross-talk between the PI3K/AKT pathway and mitogen-activated protein kinases, protein kinase A, and protein kinase C signal pathway may also play an important role.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15168354     DOI: 10.14670/HH-19.915

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  31 in total

Review 1.  Modifying radiation damage.

Authors:  Kwanghee Kim; William H McBride
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

2.  Activation of NF-kappaB in bone marrow cells of BALB/cJ mice following exposure in vivo to low doses of (137)Cs gamma-rays.

Authors:  Kanokporn Noy Rithidech; Montree Tungjai; Edgar Arbab; Sanford R Simon
Journal:  Radiat Environ Biophys       Date:  2005-11-02       Impact factor: 1.925

3.  Hsp90 Inhibitor Ganetespib Sensitizes Non-Small Cell Lung Cancer to Radiation but Has Variable Effects with Chemoradiation.

Authors:  Yifan Wang; Hui Liu; Lixia Diao; Adam Potter; Jianhu Zhang; Yawei Qiao; Jing Wang; David A Proia; Ramesh Tailor; Ritsuko Komaki; Steven H Lin
Journal:  Clin Cancer Res       Date:  2016-06-28       Impact factor: 12.531

4.  Phosphatidylinositol 3-kinase CB association with preoperative radiotherapy response in rectal adenocarcinoma.

Authors:  Wei-Dong Yu; Yi-Fan Peng; Hong-Da Pan; Lin Wang; Kun Li; Jin Gu
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

5.  MET targeting: perspectives for the radiation oncologist.

Authors:  Cyrus Chargari; Eric Deutsch
Journal:  Nat Rev Clin Oncol       Date:  2012-08-07       Impact factor: 66.675

6.  Expression of EGFRvIII in glioblastoma: prognostic significance revisited.

Authors:  Nicola Montano; Tonia Cenci; Maurizio Martini; Quintino Giorgio D'Alessandris; Federica Pelacchi; Lucia Ricci-Vitiani; Giulio Maira; Ruggero De Maria; Luigi Maria Larocca; Roberto Pallini
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

7.  Targeting PI3K and RAD51 in Barrett's adenocarcinoma: impact on DNA damage checkpoints, expression profile and tumor growth.

Authors:  Jagannath Pal; Mariateresa Fulciniti; Puru Nanjappa; Leutz Buon; Yu-Tzu Tai; Pierfrancesco Tassone; Nikhil C Munshi; Masood A Shammas
Journal:  Cancer Genomics Proteomics       Date:  2012 Mar-Apr       Impact factor: 4.069

8.  Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing.

Authors:  Hajime Isomoto; Justin L Mott; Shogo Kobayashi; Nathan W Werneburg; Steve F Bronk; Serge Haan; Gregory J Gores
Journal:  Gastroenterology       Date:  2006-11-07       Impact factor: 22.682

9.  Differential activation of NF-κB and nitric oxide in lymphocytes regulates in vitro and in vivo radiosensitivity.

Authors:  Deepak Sharma; Santosh K Sandur; R Rashmi; D K Maurya; Shweta Suryavanshi; Rahul Checker; Sunil Krishnan; K B Sainis
Journal:  Mutat Res       Date:  2010-08-21       Impact factor: 2.433

Review 10.  MicroRNA and signal transduction pathways in tumor radiation response.

Authors:  Luqing Zhao; Xiongbin Lu; Ya Cao
Journal:  Cell Signal       Date:  2013-04-17       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.